Elafibranor
Brand name: Iqirvo
Elafibranor comes in 2 pill versions in our database, in 1 strength, from 2 manufacturers. Check the imprint to tell them apart.
Elafibranor pill images
80 mg 2 pills
What is Elafibranor used for?
Elafibranor is used for biliary liver cirrhosis.
- Medicine type
- Peroxisome proliferator-activated receptor agonist
Official uses from the US prescribing label
IQIRVO is indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have had an inadequate response to UDCA, or as monotherapy in patients unable to tolerate UDCA.
This indication is approved under accelerated approval based on reduction of alkaline phosphatase (ALP). Improvement in survival or prevention of liver decompensation events have not been demonstrated. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial(s).
Limitations of Use
Use of IQIRVO is not recommended in patients who have or develop decompensated cirrhosis (e.g., ascites, variceal bleeding, hepatic encephalopathy).
From the FDA-approved label on DailyMed (published Aug 17, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.